These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4585973)

  • 21. The role of tetrahydrofolate dehydrogenase in the hepatic supply of tetrahydrobiopterin in rats.
    Stone KJ
    Biochem J; 1976 Jul; 157(1):105-9. PubMed ID: 962851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of folate antagonists on dihydrofolate reductase activity demonstrated cytochemically.
    Tzortzatou F; Hayhoe FG
    Br J Haematol; 1974 Oct; 28(2):209-16. PubMed ID: 4433479
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer research: from folate antagonism to molecular targets.
    Bertino JR
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.
    Suling WJ; Reynolds RC; Barrow EW; Wilson LN; Piper JR; Barrow WW
    J Antimicrob Chemother; 1998 Dec; 42(6):811-5. PubMed ID: 10052907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 26. Đ¢hio-containing pteridines: Synthesis, modification, and biological activity.
    Kazunin MS; Groma NV; Nosulenko IS; Kinichenko AO; Antypenko OM; Shvets VM; Voskoboinik OY; Kovalenko SI
    Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200252. PubMed ID: 36166689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
    OSBORN MJ; FREEMAN M; HUENNEKENS FM
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):429-31. PubMed ID: 13518295
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
    Gelber RH; Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 30. Histochemical pattern of tetrahydrofolate dehydrogenase in hemopoietic cells following folate antagonist treatment in vivo.
    Nano R; Gerzeli G; Gervaso MV; De Piceis Polver P; Arisi C
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(3):191-7. PubMed ID: 498204
    [No Abstract]   [Full Text] [Related]  

  • 31. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of dihydrofolic acid reductase from methotrexate-sensitive and -resistant human cell lines.
    Morandi C; Attardi G
    J Biol Chem; 1981 Oct; 256(19):10169-75. PubMed ID: 7275974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active-site directed irreversible inhibitors of dihydrofolate reductase.
    Baker BR
    Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.
    Suling WJ; Seitz LE; Pathak V; Westbrook L; Barrow EW; Zywno-Van-Ginkel S; Reynolds RC; Piper JR; Barrow WW
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2784-93. PubMed ID: 10991861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.
    Amyes SG; Smith JT
    Eur J Biochem; 1976 Jan; 61(2):597-603. PubMed ID: 2472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive inhibition of folate absorption by dihydrofolate reductase inhibitors, trimethoprim and pyrimethamine.
    Zimmerman J; Selhub J; Rosenberg IH
    Am J Clin Nutr; 1987 Sep; 46(3):518-22. PubMed ID: 3630970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 39. Nobel lecture in physiology or medicine--1988. Selective inhibitors of dihydrofolate reductase.
    Hitchings GH
    In Vitro Cell Dev Biol; 1989 Apr; 25(4):303-10. PubMed ID: 2654121
    [No Abstract]   [Full Text] [Related]  

  • 40. Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors.
    Seydel JK; Rosenfeld M; Sathish M; Wiese M; Schaper KJ; Hachtel G; Haller R; Kansy M; Dhople AM
    Lepr Rev; 1986; 57 Suppl 3():235-53. PubMed ID: 3033412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.